ClinicalTrials.gg
Active, not recruitingNCT04773457Updated Mar 17, 2026

Neutrophil Phenotypic Profiling and Surgical Site Infections in Surgical Patients

An observational study in Surgical Site Infection, sponsored by Boston Children's Hospital. Active, not recruiting at 1 site in United States. Open to participants aged 12 Months to 19 Years. Per ClinicalTrials.gov, last updated 2026-03-17.

Sponsored by Boston Children's Hospital · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
220
Ages
12 Months to 19 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 202 studies in Surgical Wound Infection with a site in United States — 31 open to participants now, 34 under way, 4 of them phase 3. Surgical Wound Infection · United States.

Planned enrollment
15th of 23
220 · median 300
Started
2024
with 10 others
Observational
23 of 202
5 open now
Primary completion
2026-12
later than 12 of 33 live
Registered
158th of 202
by date

Among the 202 studies in Surgical Wound Infection with a site in United States, this one is the 15th largest by planned enrollment of the 23 observational ones that give a count, is one of 11 that started in 2024, is one of 23 observational ones, reaches primary completion later than 12 of the 33 other live ones, and was the 158th registered.

Surgical Wound Infection

747 studies on the registry are indexed under Surgical Wound Infection; 152 are open to participants now.

Browse Surgical Wound Infection studies →

Open to participants now

31 of the 202 studies in Surgical Wound Infection with a site in United States are open now. Recruiting first, the newest first:

26 more — sign in →

All 31 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 85 Surgical Wound Infection studies recruiting now, 62 (73%) set no upper age limit and 16 (19%) stop at 75 or younger; 12 take children under 18; 14 take healthy volunteers.

This study: 12 Months to 19 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 202 studies in Surgical Wound Infection with a site in United States, or all of them as a file.
02

Study summary

Surgical site infections (SSIs) are one of the major hospital acquired infections and responsible for the most cost among the hospital acquired infections. The objective of this study is to assess the neutrophil functional profiles and their associations with SSIs.

03

Conditions studied

  • Surgical Site Infection
04

Who can participate

Ages eligible
12 Months to 19 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pediatric patients presenting for elective surgical procedures (open gastrointestinal surgery or spine fusion surgery) at Boston Children's Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • scheduled for an elective open gastrointestinal surgical procedure or spine fusion surgery

Exclusion criteria

Exclusion Criteria:

  • On chronic drugs such as chronic use
  • preexisting immunodeficiency diseases
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
220 participants (estimated)
Patient registry
No

Groups and cohorts

  • Spine Surgery

    Pediatric patients presenting for elective spine fusion surgery at Boston Children's Hospital

    Other: Surgical Site Infection

  • Abdominal Surgery

    Pediatric patients presenting for elective abdominal surgery at Boston Children's Hospital

    Other: Surgical Site Infection

Interventions

  • OtherSurgical Site Infection

    infection at the site of the surgery (spine or abdomen)

06

What researchers measure

Primary outcomes

  1. Neutrophil populations

    compare neutrophil population between patients with SSI and without SSI by delineating transcriptomic profiles

    Time frame: up to 3 days

  2. Neutrophil functional impairment

    illustrate neutrophil subpopulation associated with neutrophil functional impairment and SSIs by probing phagocytosis and reactive oxygen species formation

    Time frame: up to 3 days

07

Study locations

1 site
  • Boston Children's Hopsital
    Boston, Massachusetts 02115, United States
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2024 (actual). Primary completion is estimated for Dec 2026, 34 months after the start.

Of 65 non-industry observational studies under Surgical Wound Infection, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 53. This study's planned 34 months is above that.

Counting every sponsor, half of 68 studies reached it within 21 months; a quarter within 9 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 12, 2021
First posted
Feb 26, 2021
StartActual
Feb 1, 2024
Primary completionEst.
Dec 1, 2026
CompletionEst.
Dec 1, 2026
Last update
Mar 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04773457
Responsible party
Koichi Yuki (Principal Investigator, Boston Children's Hospital) — Principal investigator
First posted
Feb 26, 2021
Start date
Feb 1, 2024
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Mar 17, 2026

Study contacts

Koichi Yuki, MD
principal investigator · Boston Children's Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion